Articles related to VACCINES/IMMUNIZATION

Children exposed to maternal Tdap vaccination had lower pertussis toxin and diphtheria antibody concentrations at ages 3 and 4, but their responses matched controls after a preschool DTaP booster in this small Finnish follow-up.

With US measles cases reaching their highest levels in decades, a nursing-focused CE review summarizes current evidence on epidemiology, clinical presentation, complications, infection control, and critical care management of pediatric measles amid declining vaccination rates.

The FDA approved updated 2026-2027 formulations of Pfizer-BioNTech, Moderna, and Novavax COVID-19 vaccines targeting the XFG variant, aligning with advisory committee recommendations for the upcoming vaccination season.

Invasive pneumococcal disease declined among US children across vaccine eras, but incidence remained substantially higher among those with chronic medical or immunocompromising conditions, with relative disparities widening over the 25-year claims-based study.

The American Academy of Pediatrics expanded its definition of children at high risk for severe RSV disease who should receive immunization before their second RSV season, adding several congenital, developmental, and prematurity-related conditions to existing eligibility criteria.

A perspective article argues that vaccine-hesitant parents often communicate uncertainty indirectly through delays, scheduling questions, or silence rather than explicit refusal. The author proposes an “announce, detect, switch” framework that warrants prospective evaluation before broader adoption.